Company / Operating Income
CHAMPIONS ONCOLOGY, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$7.4M
FY2025
5-year range
-$7.4M / $4.6M
FY2021-FY2025
Trend
-261.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -262% YoY in FY2025, a notable deviation from the 9-year average annual change of +22%.
Based on SEC 10-K filings.
-$7M in FY2025.
Declined from $607,000 to -$7M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 261.6% year-over-year.
- Peak operating income was recorded in FY2024.
- Lowest operating income in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.4M | -261.6% |
| FY2024 | $4.6M | +650.1% |
| FY2023 | $607.0K | +65.8% |
| FY2022 | $366.0K | +119.1% |
| FY2021 | -$1.9M | -624.9% |
| FY2020 | $366.0K | +119.1% |
| FY2019 | -$1.9M | +71.8% |
| FY2018 | -$6.8M | +34.0% |
| FY2017 | -$10.3M | +22.1% |
| FY2016 | -$13.2M | -111.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026